Spain – Immunosuppressive agents – Supply of exclusive medications with active ingredients belimumab, mepolizumab, niraparib and momelotinib from the glaxosmithkline, s.a laboratory
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Supply of exclusive medications with active ingredients belimumab, mepolizumab, niraparib and momelotinib from the Glaxosmithkline, s.a laboratory